Studie: operatie verminderde psychische zorg 8% per jaar; correctie in 2020 vond geen voordeel boven niet opereren

Vermindering van het gebruik van geestelijke gezondheidszorg bij transgenders na genderbevestigende operaties: een totale bevolkingsstudie

Authors
Richard Bränström, John E. Pachankis
Journal
American Journal of Psychiatry
Year
2020

Summary

This Swedish study was widely reported in 2019 as showing that gender surgery improves long-term mental health. Using national health records, it found that people diagnosed with gender incongruence used far more mental health care than the general population. Among those who had surgery, people whose last operation was longer ago were less likely to be in treatment in 2015. Hormone treatment showed no such link. Critics pointed out that the data were a one-year snapshot rather than real follow-up, people who had died were left out, and there was no comparison with diagnosed people who had no surgery. When the authors added that comparison, surgery showed no mental health advantage. The journal published a correction in 2020 saying the original conclusion was too strong. As corrected, it gives no evidence that surgery reduces mental health care or suicide attempts.

Key findings

  • Van de 9,7 miljoen inwoners van Zweden hadden 2.679 in 2005–2015 de diagnose genderincongruentie gekregen. Ruim 70% had hormonen gekregen en 48% (1.018) had een operatie gehad.
  • In 2015 hadden gediagnosticeerde mensen ongeveer 6 keer zoveel kans als de algemene bevolking op een zorgbezoek voor depressie of angst, 3–4 keer zoveel kans op antidepressiva of angstremmers, en 6,8 keer zoveel kans om na een suïcidepoging in het ziekenhuis te worden opgenomen (22 mensen, 0,8% tegenover 0,1%).
  • Tijd sinds de start van hormonen maakte geen verschil voor geestelijke gezondheidszorg.
  • Elk jaar sinds de laatste operatie hing samen met 8% lagere kans op behandeling voor depressie of angst in 2015. De studie presenteerde dit als een voordeel op lange termijn.
  • Zelfs 10 of meer jaar na de operatie bleef geestelijke gezondheidszorg ver boven het niveau van de algemene bevolking.
  • Nadat zeven gepubliceerde brieven het ontwerp bekritiseerden, vergeleken de auteurs mensen die een operatie hadden gehad met mensen die dat niet hadden. Operatie liet op geen enkele maat een voordeel zien, en een correctie van augustus 2020 noemde de oorspronkelijke conclusie te sterk.
  • De oorspronkelijke persberichtgeving en de ongecorrigeerde conclusie worden nog steeds veel aangehaald als bewijs dat operatie de geestelijke gezondheid verbetert.

Abstract

OBJECTIVE: Despite professional recommendations to consider gender-affirming hormone and surgical interventions for transgender individuals experiencing gender incongruence, the long-term effect of such interventions on mental health is largely unknown. The aim of this study was to ascertain the prevalence of mood and anxiety disorder health care visits and antidepressant and anxiolytic prescriptions in 2015 as a function of gender incongruence diagnosis and gender-affirming hormone and surgical treatment in the entire Swedish population. METHODS: This study used the Swedish Total Population Register (N=9,747,324), linked to the National Patient Register and the Prescribed Drug Register. Among individuals who received a diagnosis of gender incongruence (i.e., transsexualism or gender identity disorder) between 2005 and 2015 (N=2,679), mental health treatment in 2015 was examined as a function of length of time since gender-affirming hormone and surgical treatment. Outcome measures were mood and anxiety disorder health care visits, antidepressant and anxiolytic prescriptions, and hospitalization after a suicide attempt. RESULTS: Compared with the general population, individuals with a gender incongruence diagnosis were about six times as likely to have had a mood and anxiety disorder health care visit, more than three times as likely to have received prescriptions for antidepressants and anxiolytics, and more than six times as likely to have been hospitalized after a suicide attempt. Years since initiating hormone treatment was not significantly related to likelihood of mental health treatment (adjusted odds ratio=1.01, 95% CI=0.98, 1.03). However, increased time since last gender-affirming surgery was associated with reduced mental health treatment (adjusted odds ratio=0.92, 95% CI=0.87, 0.98). CONCLUSIONS: In this first total population study of transgender individuals with a gender incongruence diagnosis, the longitudinal association between gender-affirming surgery and reduced likelihood of mental health treatment lends support to the decision to provide gender-affirming surgeries to transgender individuals who seek them.

Conclusion

Original conclusion (2019): in this first total population study of transgender individuals with a gender incongruence diagnosis, the longitudinal association between gender-affirming surgery and reduced likelihood of mental health treatment lends support to the decision to provide gender-affirming surgeries to transgender individuals who seek them. Correction (Am J Psychiatry, August 2020): after letters raised methodological concerns, the journal obtained further statistical review. The authors reanalysed the data comparing individuals diagnosed with gender incongruence who had received surgery with those who had not. This comparison was retrospective and not part of the original question, but the results 'demonstrated no advantage of surgery' for subsequent mood or anxiety disorder-related care visits, prescriptions, or hospitalisations after suicide attempts, and the original conclusion was judged too strong.